Company
JD Health International, Inc.
Headquarters: Beijing, China
Employees: 2,576
CEO: Mr. Enlin Jin
Market Cap
€28.36 Billion
EUR as of Jan. 1, 2023
US$30.23 Billion
JD Health International, Inc. Categories
China
languages
Healthcare
languages
Medical Care Facilities
China Healthcare
China Medical Care Facilities
Top Competitors by Market Capitalization
Industry: Medical Care Facilities
Dr. Sulaiman Al Habib Medical Services Group Company
Fresenius SE & Co KGaA
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health and wellness products through direct selling and online retail pharmacy network. The company also provides online healthcare services, such as online consultation, prescription renewal, chronic disease management, family doctor, and consumer healthcare services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, its platform allows users to book appointments and pay for services, such as general physical exams, aesthetic medicines, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Stocks & Indices
JD Health International, Inc. has the following listings and related stock indices.
Stock: FSX: 8ZN
Stock: OTC: JDHIF